Jennison Associates’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.7M | Sell |
1,235,322
-743,711
| -38% | -$10.1M | 0.01% | 348 |
|
|
2025
Q1 | $31.4M | Buy |
1,979,033
+897,027
| +83% | +$14.2M | 0.02% | 269 |
|
|
2024
Q4 | $13.3M | Buy |
1,082,006
+385,726
| +55% | +$4.75M | 0.01% | 378 |
|
|
2024
Q3 | $8.43M | Buy |
696,280
+13,023
| +2% | +$158K | 0.01% | 400 |
|
|
2024
Q2 | $7.99M | Buy |
+683,257
| New | +$7.99M | 0.01% | 403 |
|
|
2023
Q3 | – | Sell |
-355,475
| Closed | -$6.06M | – | 587 |
|
|
2023
Q2 | $6.06M | Hold |
355,475
| – | – | 0.01% | 412 |
|
|
2023
Q1 | $5.57M | Buy |
+355,475
| New | +$5.57M | 0.01% | 434 |
|